PRM-151 in the Prevention of Scarring Following Trabeculectomy
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety and tolerability of PRM-151 administered as a
subconjunctival injection and explore the effect of PRM-151 on various correlates of the
wound healing process that occurs in the eye after glaucoma filtration surgery.